204 related articles for article (PubMed ID: 10525239)
1. Preventive effects of the heparin-coated stent on restenosis in the porcine model.
Ahn YK; Jeong MH; Kim JW; Kim SH; Cho JH; Cho JG; Park CS; Juhng SW; Park JC; Kang JC
Catheter Cardiovasc Interv; 1999 Nov; 48(3):324-30. PubMed ID: 10525239
[TBL] [Abstract][Full Text] [Related]
2. Tetramethylpyrazine-eluting stents prevented in-stent restenosis in a porcine model.
Ma G; Ding S; Feng Y; Shen C; Chen L; Chen Z
J Cardiovasc Pharmacol; 2007 Aug; 50(2):201-5. PubMed ID: 17703137
[TBL] [Abstract][Full Text] [Related]
3. Reduction in neointimal formation with a stent coated with multiple layers of releasable heparin in porcine coronary arteries.
Matsumoto Y; Shimokawa H; Morishige K; Eto Y; Takeshita A
J Cardiovasc Pharmacol; 2002 Apr; 39(4):513-22. PubMed ID: 11904525
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the biocompatibility of two new diamond-like stent coatings (Dylyn) in a porcine coronary stent model.
De Scheerder I; Szilard M; Yanming H; Ping XB; Verbeken E; Neerinck D; Demeyere E; Coppens W; Van de Werf F
J Invasive Cardiol; 2000 Aug; 12(8):389-94. PubMed ID: 10953100
[TBL] [Abstract][Full Text] [Related]
5. Paclitaxel-coated Gianturco-Roubin II (GR II) stents reduce neointimal hyperplasia in a porcine coronary in-stent restenosis model.
Hong MK; Kornowski R; Bramwell O; Ragheb AO; Leon MB
Coron Artery Dis; 2001 Sep; 12(6):513-5. PubMed ID: 11696691
[TBL] [Abstract][Full Text] [Related]
6. Advanced c-myc antisense (AVI-4126)-eluting phosphorylcholine-coated stent implantation is associated with complete vascular healing and reduced neointimal formation in the porcine coronary restenosis model.
Kipshidze NN; Iversen P; Kim HS; Yiazdi H; Dangas G; Seaborn R; New G; Tio F; Waksman R; Mehran R; Tsapenko M; Stone GW; Roubin GS; Iyer S; Leon MB; Moses JW
Catheter Cardiovasc Interv; 2004 Apr; 61(4):518-27. PubMed ID: 15065150
[TBL] [Abstract][Full Text] [Related]
7. Heparin-coated Wiktor stents in human coronary arteries (MENTOR trial). MENTOR Trial Investigators.
Vrolix MC; Legrand VM; Reiber JH; Grollier G; Schalij MJ; Brunel P; Martinez-Elbal L; Gomez-Recio M; Bär FW; Bertrand ME; Colombo A; Brachman J
Am J Cardiol; 2000 Aug; 86(4):385-9. PubMed ID: 10946029
[TBL] [Abstract][Full Text] [Related]
8. Biocompatibility of tetramethylpyrazine-eluting stents in normal porcine coronary arteries.
Ma GS; Chen LJ; Chen Z; Ding S; Shen CX; Feng Y
Biomed Pharmacother; 2008 Feb; 62(2):125-9. PubMed ID: 17764890
[TBL] [Abstract][Full Text] [Related]
9. Restenosis following placement of an intracoronary heparin treated tantulum stent in the hyperlipidemic miniature swine model.
Jenkins JS; Webel R; Laughlin MH; Rowland SM; Yoklavich MF; Amann JF; Branson K; Myers PR
J Invasive Cardiol; 1995; 7(6):173-82. PubMed ID: 10155102
[TBL] [Abstract][Full Text] [Related]
10. Stents covered by an autologous arterial graft in porcine coronary arteries: feasibility, vascular injury and effect on neointimal hyperplasia.
Stefanadis C; Toutouzas K; Tsiamis E; Vlachopoulos C; Vaina S; Tsekoura D; Haldi L; Stefanadi E; Gravanis M; Toutouzas P
Cardiovasc Res; 1999 Feb; 41(2):433-42. PubMed ID: 10341842
[TBL] [Abstract][Full Text] [Related]
11. Cutting balloon combined with paclitaxel-eluting balloon for treatment of in-stent restenosis.
Kong J; Hou J; Ma L; Xing L; Jia H; Liu H; Zhang S; Yu B; Jang IK
Arch Cardiovasc Dis; 2013 Feb; 106(2):79-85. PubMed ID: 23527911
[TBL] [Abstract][Full Text] [Related]
12. Pimecrolimus and dual pimecrolimus-paclitaxel eluting stents decrease neointimal proliferation in a porcine model.
Berg R; Aragon J; Royter V; Shanley JF; Cogert G; Vermani R; Kar S; Eigler N; Litvack F
Catheter Cardiovasc Interv; 2007 Nov; 70(6):871-9. PubMed ID: 17932889
[TBL] [Abstract][Full Text] [Related]
13. Effects of beta-radiation using a holmium-166 coated balloon on neointimal hyperplasia in a porcine coronary stent restenosis model.
Kim W; Jeong MH; Park OY; Rhew JY; Bom HS; Choi SJ; Park KB; Kim EH; Kim JH; Ahn YK; Park JT; Cho JG; Park JC; Kang JC
Circ J; 2003 Jul; 67(7):625-9. PubMed ID: 12845188
[TBL] [Abstract][Full Text] [Related]
14. Influence of drug-eluting stent on inflammation during restenosis in a porcine coronary model.
Ge H; Zhou Y; Hanying M; Liu L; Nie X; Wang Z; Wang F
Acta Cardiol; 2010 Feb; 65(1):31-5. PubMed ID: 20306887
[TBL] [Abstract][Full Text] [Related]
15. [Experimental study of Mytrolimus-eluting stents on preventing restenosis in porcine coronary model].
Qiu H; Gao RL; Tang ZR; Meng L; Zhao H; Ruan YM; Zhao H; Yang YJ; Chen JL; Chen ZJ
Zhonghua Xin Xue Guan Bing Za Zhi; 2005 Jun; 33(6):561-4. PubMed ID: 16053797
[TBL] [Abstract][Full Text] [Related]
16. Histopathologic response after hydrophilic polyethylene glycol-coating stent and hydrophobic octadecylthiol-coating stent implantations in porcine coronary restenosis model.
Choe JC; Park JH; Lee HC; Park TS; Ahn J; Park JS; Lee HW; Oh JH; Choi JH; Cha KS; Yim C; Jeon S
J Mater Sci Mater Med; 2020 Nov; 31(12):122. PubMed ID: 33247775
[TBL] [Abstract][Full Text] [Related]
17. Addition of cytochalasin D to a biocompatible oil stent coating inhibits intimal hyperplasia in a porcine coronary model.
Salu KJ; Huang Y; Bosmans JM; Liu X; Li S; Wang L; Verbeken E; Bult H; Vrints CJ; De Scheerder IK
Coron Artery Dis; 2003 Dec; 14(8):545-55. PubMed ID: 14646676
[TBL] [Abstract][Full Text] [Related]
18. Paclitaxel stent coating inhibits neointimal hyperplasia at 4 weeks in a porcine model of coronary restenosis.
Heldman AW; Cheng L; Jenkins GM; Heller PF; Kim DW; Ware M; Nater C; Hruban RH; Rezai B; Abella BS; Bunge KE; Kinsella JL; Sollott SJ; Lakatta EG; Brinker JA; Hunter WL; Froehlich JP
Circulation; 2001 May; 103(18):2289-95. PubMed ID: 11342479
[TBL] [Abstract][Full Text] [Related]
19. Particle debris from a nanoporous stent coating obscures potential antiproliferative effects of tacrolimus-eluting stents in a porcine model of restenosis.
Kollum M; Farb A; Schreiber R; Terfera K; Arab A; Geist A; Haberstroh J; Wnendt S; Virmani R; Hehrlein C
Catheter Cardiovasc Interv; 2005 Jan; 64(1):85-90. PubMed ID: 15619311
[TBL] [Abstract][Full Text] [Related]
20. In vivo evaluation of a novel dexamethasone-heparin-double-coated stent for inhibition of artery restenosis and thrombosis.
Guo QK; Lu ZQ; Wang JY; Li T
J Mater Sci Mater Med; 2011 Jun; 22(6):1615-23. PubMed ID: 21556976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
